Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03233152
Title Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma (GlitIpNi)
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Universitair Ziekenhuis Brussel
Indications
Therapies
Age Groups: adult | senior
Covered Countries BEL

Facility Status City State Zip Country Details
Universitair Ziekenhuis Brussel Brussels 1090 Belgium Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field